Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 23, 2019 at 11:22 PM.

  1. #1 cafead, Apr 23, 2019 at 11:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via When Sanofi inked a massive lease in Cambridge Crossing for its Genzyme unit last year, the French drugmaker found itself in prime position for another real estate deal.

    The move opened up a lot of square footage at Sanofi Genzyme's existing facility in Kendall Square, the hottest address in the Boston biotech hub. And by subleasing that space to gene therapy player Bluebird Bio at a premium, Sanofi stands to make a profit, Boston Globe reports.

    article source
     
    Quote

Reply to Thread